A snapshot of the Australian ecosystem from a Biotech founder's lens, in Perth.
Dune Therapeutics runs large-scale genomic screening and in silico validation workflows to identify novel protein targets in rare monogenic diseases. The team, based in Perth and partnered with UWA's genetics group, combines patient cohort data with AlphaFold predictions to de-risk early-stage R&D. Current pipeline includes three undisclosed rare disease indications.
4 roles selected from Perth and adjacent Biotech teams.
Biotech founders to compare notes with.
Every founder gets a different snapshot of the ecosystem. This page is generated once for everyone like you and cached at the edge — so the next Biotech founder in Perth hits the same warm response.
Generated by an agent · refreshes every 6 hours · cohort key biotech::perth